Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown...

Question

Question

Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec 31, 2093 D

TEZOVUZLUUMUUUU $423,690.00 case Labilities and Stockholders Equity 12 Accounts payable (merchandise creditors) 13 Accrued e

CengageNOW.21 Online teaching and learning resource from Cengage learning - Google Chrome v2.cengagenow.com/ilm/take Assignme

business accounting

Add a comment Improve this question Transcribed image text

Answer 1

Answer #1

Answer:

The statement of cash flows as follow:

Kindly note, that I could not use exact labels as the same are not provided. Standard format is used. The description used may vary a little from labels.

$188,740 Statement of Cash Flows For the Year ended December 31, 20Y3 Operating Activities Net Income Adjustment to convert n

Calculations:

Cash paid for dividends = 96700-23050+18680 = $92,330

Depreciation = 166840-147700 = $19,140

Gain from Investments = 279300-239830 = $39,470

Issue of common stock = 156000 + 417000 - 93000 - 279200 = $200,800

Purchase of equipment = 705110 - 553850 = $151,260

Add a comment

Answer 2

Similar Homework Help Questions

the comparative balance sheet of livers inc. Instructions The comparative balance sheet of Livers Inc. for...

the comparative balance sheet of livers inc. Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec 31, 2093 Dec 31, 2092 Assets Cash $585.190.00 $626,100.00 228,630.00 Accounts receivable (net) 208.060.00 Inventories 641,030.00 617,620.00 Investments 0.00 239.850.00 Land 0.00 528.160.00 705.110.00 Equipment 1166.940.00) Accumulated depreciation-equipment Total assets Liabilities and Stockholders' Equity 553.850.00 (147,700.00) 52.056.850.00 $2.382.190.00 Check My Work Assignment Score: 49.13% TEZOVUZLUUMUUUU $423,690.00 case Labilities and Stockholders' Equity 12 Accounts payable...
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown...

Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets 3 Cash $626,640.00 $585,760.00 Accounts receivable (net) 226,900.00 208,390.00 Inventories 641,350.00 616,130.00 Investments 0.00 239,300.00 Land 328,730.00 0.00 Equipment 705,940.00 Accumulated depreciation-equipment (166,970.00) 553,530.00 (148,000.00) $2,055,110.00 Total assets $2,362,590.00 Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00 52,750.00 Dividends payable 23,580.00 19,500.00 Common stock, $4...
The comparative balance sheet of Navaria Inc. for December 31, 20Y3 and 20Y2, is shown as...

The comparative balance sheet of Navaria Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable $425,140.00 $404,540.00 13 Accrued expenses payable 42,020.00 52,750.00 14 Dividends...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,300.00 $404,860.00 13 Accrued expenses payable (operating expenses) 41,850.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: Dec. 31, 20Y2 Dec. 31, 20Y3 Assets 2 $625,650.00 $586,340.00 3 Cash Accounts receivable (net) 208,030.00 228,170.00 4 5 Inventories 641,480.00 617,130.00 0.00 240,290.00 6 Investments 7 Land 328,170.00 0.00 8 Equipment 552,300.00 706,070.00 (147,010.00) 9 Accumulated depreciation-equipment (165,580.00) $2,363,960.00 $2,057,080.00 10 Total assets Liabilities and Stockholders' Equity 11 1. $424,300.00 $404,860.00 12 Accounts payable (merchandise creditors) 13 Accrued expenses payable (operating expenses) 41,850.00...
he comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...

he comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $270,970 $250,900 Accounts receivable (net) 98,160 90,110 Inventories 277,110 266,820 Investments 0 103,360 Land 142,130 0 Equipment 305,730 235,880 Accumulated depreciation—equipment (71,580) (63,610) Total assets $1,022,520 $883,460 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $185,080 $174,040 Accrued expenses payable (operating expenses) 18,410 22,970 Dividends payable 10,230 7,950 Common stock, $10 par 55,220 43,290 Paid-in...

Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $260,120 $240,850 Accounts receivable (net) 94,230 86,500 Inventories 266,000 256,120 Investments 0 99,230 Land 136,440 0 Equipment 293,490 226,440 Accumulated depreciation-equipment (68,710) (61,060) Total assets $981,570 $848,080 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $177,660 $167,070 Accrued expenses payable (operating expenses) 17,670 22,050 Dividends payable 9,820 7,630 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $244,600 $230,160 Accounts receivable (net) 88,610 82,660 Inventories 250,140 244,740 Investments 0 94,820 Land 128,300 0 Equipment 275,980 216,380 Accumulated depreciation—equipment (64,610) (58,350) Total assets $923,020 $810,410 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $167,070 $159,650 Accrued expenses payable (operating expenses) 16,610 21,070 Dividends payable 9,230 7,290 Common stock,...
A comparative balance sheet of livers inc. for december 31,20Y3 and 20Y2 as it follows:...

A comparative balance sheet of livers inc. for december 31, 20Y3 and 20Y2 as it follows: Additional data obtained from an examination of the accounts in the ledger for 20Y3 are' as follows: a. The investments were sold for $175,000 cash. b. Equipment and land were acquired for cash. C. There were no disposals of equipment during the year. d. The common stock was issued for cash. e. There was a $90,000 debit to Retained Earnings for cash dividends declared.

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3...

Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $253,630 $237,840 Accounts receivable (net) 91,880 85,420 Inventories 259,370 252,910 Investments 0 97,980 Land 133,030 0 Equipment 286,170 223,600 Accumulated depreciation—equipment (67,000) (60,300) Total assets $957,080 $837,450 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $173,230 $164,980 Accrued expenses payable (operating expenses) 17,230 21,770 Dividends payable 9,570 7,540 Common stock,...

Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown...

Homework Answers

Add Answer to:
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown...

Post as a guest

Earn Coins

the comparative balance sheet of livers inc. Instructions The comparative balance sheet of Livers Inc. for...